Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04637295 · ClinicalTrials.gov registry record
Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19
A clinical trial, sponsored by University of Nebraska.
- Completed
- Registry status
- 18
- Enrollment target
NCT04637295: Completed study, sponsored by University of Nebraska.
NCT04637295 is a clinical trial that has completed, run by University of Nebraska. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04637295 has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
To examine perceptions and determinants of physical activity during the COVID-19 pandemic among cancer survivors.
Primary Outcome
Godin Leisure-Time Exercise Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-01-27 |
| Est. Completion | 2021-06-17 |
What the finished NCT04637295 record still lists
NCT04637295 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04637295 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04637295 about?
NCT04637295 is a clinical study titled "Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19". To examine perceptions and determinants of physical activity during the COVID-19 pandemic among cancer survivors.
What is the current status of trial NCT04637295?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2021-01-27. Estimated completion is 2021-06-17.
Who is sponsoring clinical trial NCT04637295?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI